SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm shares jumped following the unveiling of its new AI200 and AI250 chips aimed at the data center market, positioning the company to compete with Nvidia and AMD. The community is buzzing about the significance of this move into AI hardware, with some analysts skeptical of the long-term impact and revenue potential, while others see it as a potential game-changer. Heavy options activity and unusual trading patterns suggest strong interest and debate around the stock's future direction as it shifts from mobile chips to AI infrastructure.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending amid discussions of a potential deal with Larvotto Resources, though some express concerns about valuation and potential dilution; the community is also weighing in on the broader implications of U.S.-China trade relations and domestic antimony supply chains, with many emphasizing UAMY's position as a key domestic refiner and producer of a critical mineral.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is trending due to significant call option activity, signaling potential insider knowledge of upcoming positive news or government contracts related to rare earth elements. The community is actively discussing large call sweeps and the potential for a short squeeze. The stock is further supported by a recent joint venture in Australia and a broader focus on domestic uranium production amid geopolitical tensions.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending due to a temporary pause in gene therapy trials after a patient experienced a serious liver injury, leading to a significant drop in stock price. The community is debating whether this is an overreaction and a buying opportunity, with some focusing on the fact that it was a single patient out of many and the potential for trial resumption. Others are concerned about the implications for the gene editing sector and the company's cash burn.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending amid discussions about a potential activist investor campaign and NFL partnership, with the community debating whether these catalysts can reverse the stock's recent downturn. Some traders point to technical indicators suggesting a bottom, while others express concerns about market manipulation and the company's long-term prospects. Overall sentiment is mixed as investors weigh the potential impact of these developments on Lululemon's future performance.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as community members rally around the tokenization of Satoshi Nakamoto, viewing it as a cultural phenomenon and the 'BTC of memes'. Discussions highlight the project's potential for significant repricing and its representation of crypto's core values, with many emphasizing 'We are all Satoshi'.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc. is trending due to discussions around its low float and potential for manipulation, with some traders pointing to its recent IPO and textile business. Community members are actively sharing their trading experiences, highlighting both successful exits and caution due to previous experiences with Chinese stocks. The stock's volatile movement and trading halts are also key points of discussion.

Trump For President

The Trump Crypto token is experiencing volatility as the community debates its future and potential influence from political events. Community members are expressing concerns over potential market manipulation and overall project direction with some labeling it a scam. Despite the debate, there is speculation about a potential surge, while others remain bearish, pointing to the token's significant decline from its all-time high.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors anticipate Q3 earnings, focusing on the company's AI-driven growth strategy amid legacy business challenges. The community is discussing the potential impact of AI, a recent Palantir partnership, and government contracts on the stock's future. Some are speculating on price targets and a possible tech company rerating.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending as traders discuss its potential for a short squeeze, focusing on its low float and high insider ownership. The community is also highlighting the company's recent revenue growth, government contracts, and possible interest in a crypto treasury, while remaining aware of risks associated with China-based stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CLSD 

Anyone still here or do I need to turn off the light on my way out?

StockTwits for iOS

Clearside Biomedical Inc

 

Anyone still here or do I need to turn off the light on my way out?

Del Gue …with an E

@Del_Gue  
Just waiting nearly made a post about the implications of the Biocryst deal, but figured I would just wait until either the data drops and is good or Biocryst takes Avoralstat off their website. 
 
There&#39;a really just not much to say until either Clearside gives another update or we get some more data out of counter parties.

Jeff Castro

StockTwits Web

  
Just waiting nearly made a post about the implications of the Biocryst deal, but figured I would just wait until either the data drops and is good or Biocryst takes Avoralstat off their website. 
 
There'a really just not much to say until either Clearside gives another update or we get some more data out of counter parties.

None Ofya

@Del_Gue  
 
Our patents must be worth something plus have some hope on Xipere finally making some inroads (at the expense of Ozurdex from ABBV, which might incrementally support their stance to take a closer look at us).  
 
Rando thinks we have a small deal in CLS-AX, but i think that may be elusive (i hope i&#39;m wrong!).  
 
In terms of near-term triggers i think we get some in Q4 incl. maybe (big maybe!) China approval for Xipere, RGNX first patient dosed (which triggers a milestone for them if i&#39;m not mistaken) and updates on Aura and Biocryst programs.  
 
Lastly, our former C-level-and-now-consultants will get a cash bonus of $0.6M-0.9M if the company is sold by year end. To be fair that agreement can be extended on a monthly basis, but that is at least a yardstick. Plus a fair amount of options are vesting, especially if the BO price is higher than $19.4.  
 
Our cost base should be reasonably small. I estimate $1.5M per quarter, so that should give us some leeway.

George Ryan Steele

  
 
Our patents must be worth something plus have some hope on Xipere finally making some inroads (at the expense of Ozurdex from ABBV, which might incrementally support their stance to take a closer look at us).  
 
Rando thinks we have a small deal in CLS-AX, but i think that may be elusive (i hope i'm wrong!).  
 
In terms of near-term triggers i think we get some in Q4 incl. maybe (big maybe!) China approval for Xipere, RGNX first patient dosed (which triggers a milestone for them if i'm not mistaken) and updates on Aura and Biocryst programs.  
 
Lastly, our former C-level-and-now-consultants will get a cash bonus of $0.6M-0.9M if the company is sold by year end. To be fair that agreement can be extended on a monthly basis, but that is at least a yardstick. Plus a fair amount of options are vesting, especially if the BO price is higher than $19.4.  
 
Our cost base should be reasonably small. I estimate $1.5M per quarter, so that should give us some leeway.

Heinz Koerbel

@Del_Gue Every day the lights are fading.